A corporate news release about a new medication rollout, emphasizing improved access, affordability, and the company's strategic positioning.
Key Takeaways
- Health Canada approved a generic semaglutide injectable for chronic weight management in adults
- Product is supplied as a multi-use pre-filled pen delivering 1 mg doses
- Apotex developed the generic in partnership with Orbicular Pharmaceutical Technologies